Literature DB >> 1460349

Natural history and evolution of peripheral obstructive arterial disease.

D Duprez1.   

Abstract

The natural history of peripheral arterial occlusive disease is discussed. Severe limb-threatening ischemia is the most serious consequence of chronic arterial occlusive disease. Severe ischemia and amputation can be considered as an endpoint in peripheral vascular disease. Severe limb ischemia is relatively uncommon in isolated aortoiliac disease and this is more than twice in patients with either femoropopliteal or multisegmental disease. Subsequent studies have also demonstrated that both smoking and diabetes are associated with a substantial risk for sudden ischemia. A clear majority of about 50% deaths are caused by associated coronary artery disease, 15% to stroke and 10% to vascular disease in the abdomen. Ankle systolic blood pressure is one of the most significant factors in the progression of peripheral arterial occlusive disease and also for cardiovascular mortality. In the future, men need to know how therapies as exercise, during regimens would influence the most frequent complications besides severe limb ischemia, namely brain infarction and coronary artery disease.

Entities:  

Mesh:

Year:  1992        PMID: 1460349

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  3 in total

Review 1.  Treatment of hypertension in patients with peripheral arterial disease: an update.

Authors:  Denis L Clement
Journal:  Curr Hypertens Rep       Date:  2009-08       Impact factor: 5.369

2.  Should embolectomy be performed in late acute lower extremity arterial occlusions?

Authors:  Hikmet Iyem; M Nesimi Eren
Journal:  Vasc Health Risk Manag       Date:  2009-08-06

3.  Underutilization of Evidence-Based Smoking Cessation Support Strategies Despite High Smoking Addiction Burden in Peripheral Artery Disease Specialty Care: Insights from the International PORTRAIT Registry.

Authors:  Krishna K Patel; Philip G Jones; Edward F Ellerbeck; Donna M Buchanan; Paul S Chan; Christina M Pacheco; Gregory Moneta; John A Spertus; Kim G Smolderen
Journal:  J Am Heart Assoc       Date:  2018-10-16       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.